SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001724521-24-000180
Filing Date
2024-12-17
Accepted
2024-12-17 20:36:19
Documents
1
Period of Report
2024-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1734485773.html 4  
1 FORM 4 wk-form4_1734485773.xml 4 3385
  Complete submission text file 0001724521-24-000180.txt   4812
Mailing Address 343 OYSTER POINT BLVD SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address
Goeltz II Robert C. (Reporting) CIK: 0001653881 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38419 | Film No.: 241557400

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Issuer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)